Australian University Rankings Guide

Current Neurovascular Research (ERA Journal)

Current Neurovascular Research is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Current Neurovascular Research issn is: 1875-5739.

The fields covered by Current Neurovascular Research as part of the evaluation of Australian university research excellence are:

Cardiorespiratory Medicine and Haematology Research Rankings (Sub-Field)

Neurosciences Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Cardiorespiratory Medicine and Haematology field include:

- Annals of Thoracic Surgery
- Congestive Heart Failure
- Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine
- Current Opinion in Cardiology
- Current Problems in Cardiology
- EJVES Extra (European Journal of Vascular and Endovascular Surgery)
- Echocardiography: a journal of cardiovascular ultrasound and allied techniques
- European Heart Journal Supplements
- Hypertension
- Integrated Blood Pressure Control
- Journal of Interventional Cardiology: an international forum for global cardiovascular therapies
- Recent Patents on Cardiovascular Drug Discovery
- Seminars in Respiratory and Critical Care Medicine: pulmonology critical care allergy and immunology infections
- Seminars in Vascular Surgery
- The Internet Journal of Cardiology


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4